Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : NVSEF    crawled date : 2021 - 10 - 29    save search

FDA approves Novartis Scemblix® (asciminib), with novel mechanism of action for the treatment of chronic myeloid leukemia
Published: 2021-10-29 (Crawled : 20:00) - globenewswire.com
NVS | News | $98.1 0.84% 1.3M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVSEF | News | $96.0 52K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

treatment fda myeloid leukemia leukemia fda approval
Global CAR-T Therapy Pipeline Report 2021: Market is Expected to Stabilize and Reach $6,100 Million in 2030
Published: 2021-10-29 (Crawled : 12:00) - prnewswire.com
NVS | News | $98.1 0.84% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.18% C: 0.18%

therapy car-t
Gainers vs Losers
58% 42%

Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M twitter stocktwits trandingview |
Consumer Services

CZOO | $11.04 121.24% 11M twitter stocktwits trandingview |

BOF | $1.87 59.83% 100M twitter stocktwits trandingview |

AMST | $3.18 59.0% 67M twitter stocktwits trandingview |
Technology Services

LICN | $0.85 51.79% 13M twitter stocktwits trandingview |

WIMI | $1.04 43.37% 17M twitter stocktwits trandingview |
Technology Services

SKIL 4 | $8.045 40.89% 230K twitter stocktwits trandingview |
Information

MULN | News | $3.805 39.38% 11M twitter stocktwits trandingview |
Information

RILY | $30.01 38.17% 11M twitter stocktwits trandingview |
Finance

MTC | $3.04 35.71% 6.7M twitter stocktwits trandingview |
Technology Services


Your saved searches
Save your searches and get alerts when important news are released.